Clinical Trial Update: Erythropoietin Alfa in Elderly Subjects With Unexplained Anemia [NA]

View source ↗

Summary

A clinical trial evaluating erythropoietin alfa in elderly subjects with unexplained anemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Erythropoietin alfa (erythropoietin alfa)

Snippet

Sponsor: Stanford University | Conditions: Anemia | NA | Status: WITHDRAWN